We are committed to having a remarkable impact by going beyond medicines.
In efforts to ensure that our Grants and Donations have a greater impact and directly benefit patients, we must be more focused and strategic in our review process. In 2026, AbbVie Australia and New Zealand will only exclusively support initiatives that are aligned with AbbVie’s scientific focus areas and demonstrate a commitment to raising disease awareness, health equity, improving patient outcomes and access or advancing science and medical education.
We only accept applications at set times each year. Please submit your application by the closing dates below. Late applications will not be considered.
2026 Funding Application Closing Dates
Friday, 26th June
Friday, 16th October
What are AbbVie’s scientific areas of interest?
AbbVie’s scientific areas of interest include: rheumatology, dermatology, gastroenterology, hematology-oncology, solid tumors, urology, migraine, parkinson’s, spasticity and movement disorder, ophthalmology and hepatitis C.
For more information on applying for funding from AbbVie Australia download the AbbVie Funding Guide here.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?